Molgramostim biosimilar (Probiomed)

莫拉司亭生物类似药 (Probiomed)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (Probiomed)
Drug Alias NamerhGM-CSF (Probiomed)莫拉司亭生物仿制药 (Probiomed)Recombinant human granulocyte macrophage colony stimulating factor (Probiomed)Gramal
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2006/03/01
Country/TerritoryMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProbiomed
China Registration ClassN/A

Develop Information

Active CompaniesProbiomed
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA03
Related LinksN/A